In-Person
Uptake and Standardization of Treatment Advances Through an Integrated Network (SUSTAIN) for Bispecific Antibody Therapy
Hosted by University of Kentucky Healthcare CE Central
May 11, 2026 Location TBD
About This Event
This continuing education program addresses critical gaps in the delivery of Bispecific Antibody (BsAb) therapy for Multiple Myeloma patients in Kentucky, particularly in rural communities. The course will equip oncology providers with protocols for BsAb administration, toxicity management, patient selection strategies, and emergency response systems to enable safe and effective local delivery of this advanced therapy.
Sign in to unlock everything networkED.global adds to this event
We enrich every event with details scattered across the web — organized, verified, in one place:
- Earning CE? CE credits, accreditation, and which licenses it counts toward — tracked automatically.
- Speaking? Call-for-proposal deadlines and submission details.
- Exhibiting or sponsoring? Exhibit and sponsorship opportunities.
- Hosting events? Be connected directly to your target audiences.
Plus full agenda, pricing, registration, contacts, and topics covered.